Sumitomo Mitsui Trust Holdings, Inc. Incyte Corp Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 450,471 shares of INCY stock, worth $38.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
450,471
Previous 473,186
4.8%
Holding current value
$38.5 Million
Previous $28.7 Million
7.07%
% of portfolio
0.02%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding INCY
# of Institutions
732Shares Held
202MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.62 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.82 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.72 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.25 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$843 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $19B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...